BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 8055623)

  • 1. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
    Georgieva NI; Boysen G; Bordeerat N; Walker VE; Swenberg JA
    Toxicol Sci; 2010 Jun; 115(2):322-9. PubMed ID: 20176624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
    Pianalto KM; Hartman JH; Boysen G; Miller GP
    Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3-Butadiene: Biomarkers and application to risk assessment.
    Swenberg JA; Bordeerat NK; Boysen G; Carro S; Georgieva NI; Nakamura J; Troutman JM; Upton PB; Albertini RJ; Vacek PM; Walker VE; Sram RJ; Goggin M; Tretyakova N
    Chem Biol Interact; 2011 Jun; 192(1-2):150-4. PubMed ID: 20974116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the 1,4-Bis(2'-deoxyadenosin-N(6)-yl)-2S,3S-butanediol intrastrand DNA cross-link arising from butadiene diepoxide in the human N-ras codon 61 sequence.
    Xu W; Merritt WK; Nechev LV; Harris TM; Harris CM; Lloyd RS; Stone MP
    Chem Res Toxicol; 2007 Feb; 20(2):187-98. PubMed ID: 17256975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the 1,4-bis(2'-deoxyadenosin-N6-yl)-2R,3R-butanediol cross-link arising from alkylation of the human N-ras codon 61 by butadiene diepoxide.
    Merritt WK; Nechev LV; Scholdberg TA; Dean SM; Kiehna SE; Chang JC; Harris TM; Harris CM; Lloyd RS; Stone MP
    Biochemistry; 2005 Aug; 44(30):10081-92. PubMed ID: 16042385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomonitoring of 1,3-butadiene and related compounds.
    Osterman-Golkar S; Bond JA
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):907-15. PubMed ID: 8933033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of toxicologic data in mechanistic risk assessment: 1,3-butadiene as a case study.
    Bond JA; Himmelstein MW; Medinsky MA
    Int Arch Occup Environ Health; 1996; 68(6):415-20. PubMed ID: 8891778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
    Bond JA; Medinsky MA
    Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation.
    Himmelstein MW; Turner MJ; Asgharian B; Bond JA
    Carcinogenesis; 1994 Aug; 15(8):1479-86. PubMed ID: 8055623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene.
    Himmelstein MW; Asgharian B; Bond JA
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
    Csanády GA; Guengerich FP; Bond JA
    Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace.
    Bond JA; Recio L; Andjelkovich D
    Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats.
    Sweeney LM; Schlosser PM; Medinsky MA; Bond JA
    Carcinogenesis; 1997 Apr; 18(4):611-25. PubMed ID: 9111190
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.